Silicon Laboratories, Inc. (SLAB)

From the record

Silicon Laboratories, Inc.'s filings since 2017 show 1 warning event: an auditor change (8-K item 4.01, the latest 2025-03-06) (its current reports).

From the record

Silicon Laboratories, Inc.'s 10 filed years say what it did: revenue went from $698 million in fiscal 2016 to $785 million in fiscal 2026, up 1.3% a year; it rose in 6 of 9 years; the deepest fall was 45% from fiscal 2018 to fiscal 2019; net income was positive in 0 of 3 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2026-01-03, Silicon Laboratories, Inc.'s diluted share count shrank about 3.2% a year, and dividends and buybacks returned about 100% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 5 sales (4 under scheduled 10b5-1 plans) and 0 purchases of their own stock on the open market in the year to 2026-09-30 (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2026-01-03, Silicon Laboratories, Inc. lost about 6 cents for every dollar of shareholders' money, and gross profitability: its products earned about 36 cents per dollar of everything the company owns. Leverage: it owed about 14 cents per dollar of assets, and net share issuance: its share count grew 1.6% over the year (the filed statements).

From the record

Silicon Laboratories, Inc.'s standing among 97 graded names in its industry family: revenue of $785 million in fiscal 2026 ranks in the top 49% by size; a net margin of -8.3% ranks in the bottom 36%; revenue growth of -8.5% a year over the last 3 filed years ranks in the bottom 24% (its annual reports).

From the record

Silicon Laboratories, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Johnson, Robert Matthew (President & CEO, as filed), filing under that title since 2022-02-17, 4.7 years (top 49% of its family); the 12 officers and directors filing in the last fifteen months have been on the record a median of 8.7 years (top 26%); 6 officer or director changes were reported on Form 8-K since 2023-11-13, against the 12 people in charge now (top 45%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Silicon Laboratories, Inc.'s room to grow, from the newest filed statements (fiscal 2026): cash of $364 million against no long-term debt tagged leaves 28.7% of its assets as net cash, top 20% of its family; cash from operations less capital spending is 8.4% of revenue (top 42%); a gross margin of 58.2% (top 16%); research spending of 45% of revenue (top 21%) (its annual report).

From the record

Silicon Laboratories, Inc.'s growth drivers, from the filed years to fiscal 2026: revenue grew -8.5% a year over the last three filed years against 1.3% over all 10, slowing (bottom 35% of its family); the newest year grew 33.7% (top 25%); research spending grew 2% a year (bottom 32%); capital spending grew 4.1% a year (bottom 43%) (its annual reports). Silicon Laboratories, Inc. reported 2 product lines in fiscal 2025: Industrial Commercial at $445 million (57%), Home Life at $340 million (43%); 2 of 2 grew against the year before (its annual report).

From the record

Silicon Laboratories, Inc.'s newest year against its own record: revenue of $785 million in fiscal 2026 came in 77.9% above the $441 million its prior three years' pace pointed to (top 18% of its family); net income of $65 million against a prior three-year average of $113 million (top 31%); a net margin of -8.3% against -18.5% before (top 30%) (its annual reports).